HomeGERN • NASDAQ
add
Geron Corp
Previous close
$1.42
Day range
$1.40 - $1.60
Year range
$1.04 - $2.01
Market cap
980.03M USD
Avg Volume
17.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 48.02M | 1.01% |
Operating expense | 113.10M | -23.12% |
Net income | -28.86M | -13.85% |
Net profit margin | -60.11 | -12.71% |
Earnings per share | -0.02 | 40.45% |
EBITDA | -8.42M | 57.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 357.92M | -11.97% |
Total assets | 570.54M | -3.91% |
Total liabilities | 344.67M | 9.96% |
Total equity | 225.87M | — |
Shares outstanding | 640.54M | — |
Price to book | 4.06 | — |
Return on assets | -3.74% | — |
Return on capital | -5.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -28.86M | -13.85% |
Cash from operations | -22.07M | 49.78% |
Cash from investing | 21.14M | 120.43% |
Cash from financing | 378.00K | -99.77% |
Net change in cash | -553.00K | -102.96% |
Free cash flow | -239.12K | 98.57% |
About
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Founded
1990
Headquarters
Website
Employees
258
